TTM
69.8%
YoY change
−5.65pp
Trough year (1986)
-264.1%
Peak year (2002)
99.6%
Latest annual
70.5%
Gross Margin history chart for Biogen (BIIB) from 1985 to 2025
Latest: 70.5%
Gross Margin change chart for Biogen (BIIB) from 1985 to 2025
Latest: −5.65pp
Gross Margin history table for Biogen (BIIB) from 1985 to 2025
| 2025 | 70.5% | -5.65pp | ||
| 2024 | 76.1% | +1.88pp | ||
| 2023 | 74.2% | -3.36pp | ||
| 2022 | 77.6% | -3.18pp | ||
| 2021 | 80.8% | -5.78pp | ||
| 2020 | 86.6% | +0.17pp | ||
| 2019 | 86.4% | -0.10pp | ||
| 2018 | 86.5% | -0.22pp | ||
| 2017 | 86.7% | -0.76pp | ||
| 2016 | 87.5% | -0.99pp | ||
| 2015 | 88.5% | +0.54pp | ||
| 2014 | 87.9% | +0.30pp | ||
| 2013 | 87.6% | -2.48pp | ||
| 2012 | 90.1% | -0.65pp | ||
| 2011 | 90.8% | -0.76pp | ||
| 2010 | 91.5% | +0.24pp | ||
| 2009 | 91.3% | +1.08pp | ||
| 2008 | 90.2% | +0.76pp | ||
| 2007 | 89.4% | -0.34pp | ||
| 2006 | 89.8% | +11.58pp | ||
| 2005 | 78.2% | +12.93pp | ||
| 2004 | 65.3% | +118.24pp | ||
| 2003 | -53.0% | -152.61pp | ||
| 2002 | 99.6% | +12.74pp | ||
| 2001 | 86.9% | +0.43pp | ||
| 2000 | 86.5% | +0.45pp | ||
| 1999 | 86.0% | -0.61pp | ||
| 1998 | 86.6% | -1.80pp | ||
| 1997 | 88.4% | -1.27pp | ||
| 1996 | 89.7% | -3.37pp | ||
| 1995 | 93.1% | -0.56pp | ||
| 1994 | 93.6% | -2.33pp | ||
| 1993 | 96.0% | -2.25pp | ||
| 1992 | 98.2% | +68.74pp | ||
| 1991 | 29.5% | +0.14pp | ||
| 1990 | 29.3% | +17.76pp | ||
| 1989 | 11.6% | +14.01pp | ||
| 1988 | -2.4% | +141.76pp | ||
| 1987 | -144.2% | +119.88pp | ||
| 1986 | -264.1% | -334.26pp | ||
| 1985 | 70.2% | — |
- 202570.5%-5.65pp
- 202476.1%+1.88pp
- 202374.2%-3.36pp
- 202277.6%-3.18pp
- 202180.8%-5.78pp
- 202086.6%+0.17pp
- 201986.4%-0.10pp
- 201886.5%-0.22pp
- 201786.7%-0.76pp
- 201687.5%-0.99pp
- 201588.5%+0.54pp
- 201487.9%+0.30pp
- 201387.6%-2.48pp
- 201290.1%-0.65pp
- 201190.8%-0.76pp
- 201091.5%+0.24pp
- 200991.3%+1.08pp
- 200890.2%+0.76pp
- 200789.4%-0.34pp
- 200689.8%+11.58pp
- 200578.2%+12.93pp
- 200465.3%+118.24pp
- 2003-53.0%-152.61pp
- 200299.6%+12.74pp
- 200186.9%+0.43pp
- 200086.5%+0.45pp
- 199986.0%-0.61pp
- 199886.6%-1.80pp
- 199788.4%-1.27pp
- 199689.7%-3.37pp
- 199593.1%-0.56pp
- 199493.6%-2.33pp
- 199396.0%-2.25pp
- 199298.2%+68.74pp
- 199129.5%+0.14pp
- 199029.3%+17.76pp
- 198911.6%+14.01pp
- 1988-2.4%+141.76pp
- 1987-144.2%+119.88pp
- 1986-264.1%-334.26pp
- 198570.2%—
Gross Margin values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's latest reported gross margin is 69.8%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Biogen (BIIB) gross margin totalled 70.47% – contracted 5.7 percentage points year-over-year.
Across the available history, gross margin reached its high of 99.64% in 2002 and its low of -264.06% in 1986.
Biogen Gross Margin by Year
Biogen Gross Margin 2025: 70.5%
Biogen gross margin in 2025 was 70.47%, contracted 5.7 percentage points from 2024.
Biogen Gross Margin 2024: 76.1%
2024's gross margin for Biogen came in at 76.12%, expanded 1.9 percentage points from 2023.
Biogen Gross Margin 2023: 74.2%
Biogen posted gross margin of 74.24% in 2023, contracted 3.4 percentage points from 2022.
Biogen Gross Margin 2022: 77.6%
In 2022, Biogen reported gross margin of 77.61%, contracted 3.2 percentage points from 2021.
Biogen Gross Margin 2021: 80.8%
Biogen gross margin in 2021 was 80.79%.
See more financial history for Biogen (BIIB).
Sector peers by Gross Margin
Healthcare peers of Biogen (BIIB), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation